vTv Therapeutics (VTVT) Current Assets (2014 - 2026)

vTv Therapeutics has disclosed Current Assets across 13 years of filings, most recently posting $87.6 million for Q2 2026.

• In Q2 2026, Current Assets rose 232.1% year-over-year to $87.6 million; the TTM figure through Jun 2026 stood at $87.6 million (up 232.1% YoY), while the FY2025 annual figure was $89.9 million, up 135.86% from the prior year.
• Current Assets came in at $87.6 million for Q2 2026 at vTv Therapeutics, down from $98.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $99.5 million in Q3 2025 to a low of $10.1 million in Q3 2023.
• Average Current Assets over 5 years is $42.8 million, with a median of $31.3 million recorded in 2022.
• Year-over-year, Current Assets tumbled 64.82% in 2023 and surged 324.28% in 2024.
• Over 5 years, Current Assets stood at $27.1 million in 2022, then plunged by 60.67% to $10.7 million in 2023, then soared by 257.63% to $38.1 million in 2024, then jumped by 135.86% to $89.9 million in 2025, then fell by 2.56% to $87.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $87.6 million in Q2 2026, $98.8 million in Q1 2026, and $89.9 million in Q4 2025.